The Rise of Biosimilars: Regulatory Pathways and Market Outlook
Biosimilars are changing the way healthcare systems manage the high cost of advanced medicines.
September 19, 2025
by Nurah Ekhlaque
Falling off the Patent Cliff: Patent Expirations in 2025 and Onwards
In the early 2010s, a new phenomenon hit the pharmaceutical industry – the patent cliff.
March 31, 2025
by Suzanne Elvidge
Reverse Mergers Among Chinese Pharma Firms are Rising
Qilu Pharmaceutical applied for marketing of nusinersen injection, becoming the second in China. Nusinersen has a complex history due to high price. SMA treatment has multiple drugs and Chinese firms are making progress, with unmet needs remaining.
January 23, 2025
by Xiaobin
Generic = Branded Drug, What are the Facts?
It is no secret that the U.S. military does not trust the quality of generic drugs, and their disagreements and disagreements with the FDA over the quality control of generic drugs have long been made public.
July 3, 2024
by Krebs Qin
IGBA launches whitepaper on global generic and biosimilar medicines industry
It covers opportunities, challenges and disruptions for the industry, vision for 2030 as well as actions needed to achieve this vision.
July 8, 2021
by expresspharma
Chinese patent reforms to bolster pharma innovation
Market research suggests the new drug patent reforms in China, in addition to other regulatory changes, will incentivise innovative pharma research.
June 18, 2021
by europeanpharmaceuticalreview
Generic Pharmasec signs distribution and marketing pact with Abbott Point of Care
The company has entered into an agreement with Abbott Point of Care (APOC), the medical and diagnostics devices division of Abbott, for the distribution, marketing and promotion of the entire range of products by APOC in the entire country of India.
June 1, 2021
by expresspharma
The Biden effect on India Pharma Inc
Stakeholders share their views and insights on the impact of a change of guard at the White House and outline India Pharma Inc's expectations from the Biden administration.
December 2, 2020
by expresspharma
Lannett Launches Authorized Generic of Tirosint® (Levothyroxine Sodium Capsules)
Lannett Company, Inc. announced that it has commenced the launch of the authorized generic of Tirosint® (Levothyroxine Sodium Capsules USP).
November 5, 2020
by prnewswire
Dr Reddy’s launches generic opioid antagonist injection in US
The product is a generic version of ADAPT Pharma Operations's Narcan injection.
March 23, 2020
by expresspharma
Dr Reddy’s launches generic Ziprasidone Mesylate for injection in US
Dr Reddy’s Laboratories said it has launched in the US generic Ziprasidone Mesylate for injection used for treatment of acute agitation in schizophrenic patients.
March 20, 2020
by expresspharma
Mylan generic of lung cancer drug Alimta approved
Mylan NV’s generic version Eli Lilly and Co’s lung cancer drug, Alimta, has been given tentative approval by the FDA.
September 4, 2019
by europeanpharmaceuticalreview